RxSight, Inc. Appoints Raymond W. Cohen to its Board of Directors

ALISO VIEJO, Calif.—RxSight, Inc., (Nasdaq: RXST) an ophthalmic medical device company focused on improving vision after cataract surgery, has announced the appointment of Raymond W. Cohen to its board of directors. Cohen, an accredited public company director and medical technology executive, has over four decades of industry experience, according to the announcement. “We are thrilled to welcome Raymond W. Cohen to the RxSight board of directors,” said J. Andy Corley, chairman of the board at RxSight.